The increase in chronic and lifestyle-related diseases requires advances in digital detection through biomarker data to address the growing need for disease management and healthcare transformation.
A new company says healthcare settings are not equipped to deal with developments in technology and healthcare demands. By capturing data off common smart device sensors, they’ve developed a digital biomarker platform to detect diseases earlier.
Savan Devani, CEO of BioTrillion, explains, “Globally and annually, trillions of dollars and data are wasted in the healthcare industry. Early disease signs are too often missed, dismissed or ineffectively measured. Digital biomarkers give us a better way.”